Navigation Links
FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
Date:11/2/2011

SILVER SPRING, Md., Nov. 2, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Senile aortic valve stenosis is a progressive, age-related disease caused by calcium deposits on the aortic valve that cause the valve to narrow. As the heart works harder to pump enough blood through the smaller valve opening, the heart eventually weakens, which can lead to problems such as fainting, chest pain, heart failure, irregular heart rhythms (arrhythmias), or cardiac arrest.  

Once symptoms of senile aortic stenosis occur, more than half of patients die within two years. To restore normal blood flow, patients with severe aortic valve stenosis need open-heart surgery to replace the diseased valve. However, the procedure is too risky for some patients.

"Surgery to replace the aortic valve is an effective treatment for severe senile aortic valve stenosis. The Sapien Transcatheter Heart Valve (THV) is an example of an innovative new device that will provide some people with this condition who can't undergo open heart surgery with the option of valve replacement," said Jeffrey Shuren, M.D., director of the FDA's Center for Devices and Radiological Health. "The agency remains committed to working with companies who are developing breakthrough treatments that will have a significant impact on patient care in the U.S."

The Sapien THV is made of cow tissue and polyester supported with a stainless steel mesh frame. To replace the diseased valve, the Sapien THV is compressed into the end of a long, thin, tube-like device called a delivery catheter. The delivery catheter, which is slightly wider than a pencil, and the Sapien THV are inserted into the femoral artery through a small cut in the leg and threaded to the si
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)...  Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... on September 10, 2015. DATE: Thursday, September ... http://tinyurl.com/sep10pre This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:9/4/2015)... (NYSE: AGN ) a leading global pharmaceutical company, today ... Allergan, will provide an overview and update of the Company,s ... New York, NY . Logo ... take place on Thursday, September 17, 2015 at 10:35 AM ... 42nd Street, New York, NY 10017.  ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... , , INCLINE VILLAGE, Nev., Dec. 2 PDL ... has established the per share amount of the previously announced $200 ... paid on December 15, 2009 to all holders of the Company,s ... previously estimated the approximate per share amount of the dividend at ...
... , NANJING, China, ... "Company") (NYSE: SCR ), a leading pharmaceutical ... and proprietary pharmaceuticals in China, today reported that its,subsidiary ... suspended production of all its products in order to ...
Cached Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and the surrounding communities, is launching a charity effort to provide for the ... referred to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind is ... is quite common. Mold can grow anywhere - on carpet, clothing, food, paper, and ... excessive moisture and water in the home is key to preventing mold growth, which ...
(Date:9/4/2015)... Grants Pass, OR (PRWEB) , ... September 04, ... ... Center that markets a line of personal humidifying medical devices, announced its only ... global climate, explains Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is ...
(Date:9/4/2015)... NY (PRWEB) , ... September 04, 2015 , ... Lalonde ... qualifying heat, and followed up with victory in the men’s 400 meters final, with ... Senior Track and Field Championships in San Jose, Costa Rica in August 2015. The ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... care systems around the world are failing to use ... and reduced quantity and quality of life, according to ... "Failures to use research evidence to inform decision-making ... Sharon Straus, a geriatrician and director of knowledge translation ...
... Stavanger,s Reading Centre asks if something is lost in switching ... The process of reading and writing involves a number ... receives feedback from our motor actions, together with the sensation ... is significantly different from those we receive when touching and ...
... results of a genetic blood test and a five-minute ... older adults, many of whom were destined to develop ... John Woodard, Ph.D., associate professor of ... and Institute of Gerontology at Wayne State University, is ...
... , TUESDAY, Jan. 18 (HealthDay News) -- As the final ... sobering fact from a new study: One in every 12 ... the blood alcohol content (BAC) of 382 adults following 13 ... of Minnesota found that 8 percent of fans surveyed had ...
... are more likely to have seriously considered suicide than their ... of Toronto , In a paper published online this week ... specific differences among a sample of 6,647 adults, of whom ... The study found that men from divorced families had more ...
... 18 (HealthDay News) -- Genetics appear to play a role ... feelings, a new study suggests. Researchers collected DNA from ... least once in their lives. The teens were also asked ... problems they had experienced. The study found that binge ...
Cached Medicine News:Health News:Health-care systems not using best evidence in decision-making 2Health News:Better learning through handwriting 2Health News:Better learning through handwriting 3Health News:Wayne State University study predicts risk of memory loss in healthy, older adults 2Health News:One in 12 Fans Leaves Major Sports Events Drunk: Study 2Health News:One in 12 Fans Leaves Major Sports Events Drunk: Study 3Health News:Parental divorce linked to suicidal thoughts 2
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
... Stabilizer Plastazote® with plastic anterior ... straps. Chin cradle reduces rotation. ... be interchanged for individualized fitting.,Philadelphia™ ... standard Philadelphia Collar for added ...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Optical Mini Urethrotome for telescope 3.3 mm, 0...
Medicine Products: